Massimo Aglietta
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Immunology
- Co-authors
- Sara LonardiKa Yeung Mark WongBart NeynsEric Van CutsemAlain HendliszMichael J. OvermanFabio GelsominoMing Lei
- Topics
- Colorectal Cancer Treatments and Studies (14 papers)Melanoma and MAPK Pathways (10 papers)Cancer Immunotherapy and Biomarkers (8 papers)
- Partner nations
- ItalyUnited StatesAustralia
In The Last Decade
Massimo Aglietta
29 papers receiving 437 citations
Hit Papers
Peers
Comparison fields: 5 of 47
- Oncology 378
- Pathology and Forensic Medicine 144
- Molecular Biology 106
- Pulmonary and Respiratory Medicine 99
- Immunology 65
Countries citing papers authored by Massimo Aglietta
This map shows the geographic impact of Massimo Aglietta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Aglietta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Aglietta more than expected).
Fields of papers citing papers by Massimo Aglietta
This network shows the impact of papers produced by Massimo Aglietta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Aglietta. The network helps show where Massimo Aglietta may publish in the future.
Co-authorship network of co-authors of Massimo Aglietta
This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Aglietta. A scholar is included among the top collaborators of Massimo Aglietta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Aglietta. Massimo Aglietta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 19 | |
| 3 | Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142breakdown → | 154 |
| 4 | 9 | |
| 5 | 5 | |
| 6 | 8 | |
| 7 | 13 | |
| 8 | 14 | |
| 9 | 25 | |
| 10 | 24 | |
| 11 | 23 | |
| 12 | 11 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 2 | |
| 16 | 7 | |
| 17 | 13 | |
| 18 | 4 | |
| 19 | 10 | |
| 20 | 2 |
About Massimo Aglietta
Massimo Aglietta is a scholar working on Oncology, Pathology and Forensic Medicine and Computational Theory and Mathematics, having authored 29 papers that have together received 444 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Melanoma and MAPK Pathways (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (378 citations), Pathology and Forensic Medicine (144 citations) and Cancer Research (52 citations). Massimo Aglietta has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Sara Lonardi, Ka Yeung Mark Wong, Bart Neyns, Eric Van Cutsem, Alain Hendlisz, Michael J. Overman, Fabio Gelsomino, Ming Lei, Thierry André and Andrew Hill. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.